× Industry Reports Services Press Release Contact us About us

Europe Clinical Trial Management System Market Share By Delivery Mode (Web, Cloud, On Premise), By End-use (Pharmaceutical & Biopharmaceutical Companies, Clinical Research Organizations, Healthcare Providers), By Component (Software, Hardware, Services), By Product (Enterprise Based, Site Based), Industry Analysis Report, Regional Outlook (U.S., Canada), Application Potential, Competitive Market Share & Forecast, 2020 - 2026

Published Date: February 2020 | Publisher: Graphical Research Report ID: GR1286 | Delivery : PDF

Report Content

Chapter 1.     Methodology

1.1.   Definition and forecast parameters

1.1.1.  Definitions

1.1.2.  Methodology and forecast parameters        

1.2.   Data sources 

1.3.   References & sources

1.3.1.  Secondary

1.3.2.  Primary

Chapter 2.     Executive Summary

2.1.   Europe clinical trial management system industry summary, 2015 - 2026

2.1.1.  Country trends

2.1.2.  Component trends

2.1.3.  Product trends

2.1.4.  Delivery mode trends

2.1.5.  End-use trends

Chapter 3.     Industry Insights

3.1.   Industry segmentation

3.2.   Industry outlook, 2015 - 2026

3.3.   Major factor analysis

3.3.1.  Drivers

3.3.1.1.   Outsourcing of clinical trials

3.3.1.2.   Enhanced R&D expenditure of life science and clinical research industries

3.3.1.3.   Increased number of clinical trials

3.3.1.4.   Technological advancements

3.3.2.  Restraints & challenges

3.3.2.1.   High cost of clinical trial management system

3.4.   Regulatory landscape

3.4.1.  Europe

3.5.   Technology landscape

3.6.   Porter’s analysis

3.7.   Competitive review, 2019

3.8.   PESTEL analysis

Chapter 4.         Europe Clinical Trial Management System Market, By Component

4.1.   Key trends in Europe clinical trial management system, by component

4.2.   Software

4.2.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.3.   Hardware

4.3.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

4.4.   Services

4.4.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

Chapter 5.         Europe Clinical Trial Management System Market, By Product

5.1.   Key trends in Europe clinical trial management system, by product

5.2.   Enterprise based

5.2.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

5.3.   Site based

5.3.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

Chapter 6.         Europe Clinical Trial Management System Market, By Delivery Mode

6.1.   Key trends in Europe clinical trial management system, by delivery mode

6.2.   Web

6.2.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

6.3.   Cloud

6.3.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

6.4.   On premise

6.4.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

Chapter 7.         Europe Clinical Trial Management System Market, By End-use

7.1.   Key trends in Europe clinical trial management system, by end-use

7.2.   Pharmaceutical and biopharmaceutical companies

7.2.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

7.3.   Clinical research organizations

7.3.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

7.4.   Healthcare providers

7.4.1.  Market estimates and forecast, by country, 2015 - 2026  (USD Million)

Chapter 8.         Europe Clinical Trial Management System Market, By Country

8.1.   Key trends in Europe clinical trial management system, by country

8.2.   Germany

8.2.1.   Market estimates and forecast, by component, 2015 - 2026  (USD Million)

8.2.2.   Market estimates and forecast, by product, 2015 - 2026  (USD Million)

8.2.3.   Market estimates and forecast, by delivery mode, 2015 - 2026  (USD Million)

8.2.4.   Market estimates and forecast, by end-use, 2015 - 2026  (USD Million)

8.3.   UK

8.3.1.   Market estimates and forecast, by component, 2015 - 2026  (USD Million)

8.3.2.   Market estimates and forecast, by product, 2015 - 2026  (USD Million)

8.3.3.   Market estimates and forecast, by delivery mode, 2015 - 2026  (USD Million)

8.3.4.   Market estimates and forecast, by end-use, 2015 - 2026  (USD Million)

8.4.   France

8.4.1.   Market estimates and forecast, by component, 2015 - 2026  (USD Million)

8.4.2.   Market estimates and forecast, by product, 2015 - 2026  (USD Million)

8.4.3.   Market estimates and forecast, by delivery mode, 2015 - 2026  (USD Million)

8.4.4.   Market estimates and forecast, by end-use, 2015 - 2026  (USD Million)

8.5.   Spain

8.5.1.   Market estimates and forecast, by component, 2015 - 2026  (USD Million)

8.5.2.   Market estimates and forecast, by product, 2015 - 2026  (USD Million)

8.5.3.   Market estimates and forecast, by delivery mode, 2015 - 2026  (USD Million)

8.5.4.   Market estimates and forecast, by end-use, 2015 - 2026  (USD Million)

8.6.   Italy

8.6.1.   Market estimates and forecast, by component, 2015 - 2026  (USD Million)

8.6.2.   Market estimates and forecast, by product, 2015 - 2026  (USD Million)

8.6.3.   Market estimates and forecast, by delivery mode, 2015 - 2026  (USD Million)

8.6.4.   Market estimates and forecast, by end-use, 2015 - 2026  (USD Million)

8.7.   Poland

8.7.1.   Market estimates and forecast, by component, 2015 - 2026  (USD Million)

8.7.2.   Market estimates and forecast, by product, 2015 - 2026  (USD Million)

8.7.3.   Market estimates and forecast, by delivery mode, 2015 - 2026  (USD Million)

8.7.4.   Market estimates and forecast, by end-use, 2015 - 2026  (USD Million)

8.8.   Russia

8.8.1.   Market estimates and forecast, by component, 2015 - 2026  (USD Million)

8.8.2.   Market estimates and forecast, by product, 2015 - 2026  (USD Million)

8.8.3.   Market estimates and forecast, by delivery mode, 2015 - 2026  (USD Million)

8.8.4.   Market estimates and forecast, by end-use, 2015 - 2026  (USD Million)

Chapter 9.     Company Profiles

9.1.   Bioclinica

9.1.1.  Business overview

9.1.2.  Financial data

9.1.3.  Product landscape

9.1.4.  Strategic outlook

9.2.   Bio-Optronics, Inc

9.2.1.  Business overview

9.2.2.  Financial data

9.2.3.  Product landscape

9.2.4.  Strategic outlook

9.3.   DataTrak International

9.3.1.  Business overview

9.3.2.  Financial data

9.3.3.  Product landscape

9.3.4.  Strategic outlook

9.4.   DSG Inc.

9.4.1.  Business overview

9.4.2.  Financial data

9.4.3.  Product landscape

9.4.4.  Strategic outlook

9.5.   Forte

9.5.1.  Business overview

9.5.2.  Financial data

9.5.3.  Product landscape

9.5.4.  Strategic outlook

9.6.   MasterControl Inc.

9.6.1.  Business overview

9.6.2.  Financial data

9.6.3.  Product landscape

9.6.4.  Strategic outlook

9.7.   Medidata Solutions, Inc.

9.7.1.  Business overview

9.7.2.  Financial data

9.7.3.  Product landscape

9.7.4.  Strategic outlook

9.8.   Merge Healthcare (IBM Watson Health)

9.8.1.   Business overview

9.8.2.   Financial data

9.8.3.   Product landscape

9.8.4.   Strategic outlook

9.9.   OmniComm Systems, Inc.

9.9.1.   Business overview

9.9.2.   Financial data

9.9.3.   Product landscape

9.9.4.   Strategic outlook

9.10. Oracle

9.10.1. Business overview

9.10.2. Financial data

9.10.3. Product landscape

9.10.4. Strategic outlook


Select License

Europe Clinical Trial Management System Market | By Delivery Mode & End-use


Related Reports
Why Choose us?
  • On-Time Delivery - logo On-Time Delivery
  • Assured Quality - logo Assured Quality
  • Industry Experts - logo Industry Experts
  • Payment Security - logo Payment Security
Share Social-media